⭐ Worth Watching

Optiemus Infracom Limited has published its unaudited standalone and consolidated financial results for the quarter and half year ended 30th September, 2026, on its website and in newspapers.

Global Defence Industries Ltd has published unaudited financial results for the quarter and half year ended September 30, 2026, showing a net profit of ₹571.43 crore and a total income from operations of ₹2,909.94 crore.

IndusInd Bank has partnered with J.P. Morgan Payments to enhance outward remittance experience by expanding coverage to 123 currencies. The collaboration will enable direct local-currency settlements and simplify the remittance journey for IndusInd Bank customers.

Indian Hume Pipe Company Limited has published its unaudited quarterly financial results for the 2nd quarter and 1st half year ended September 30, 2026, showing a total income from operations of INR 29,913.36 lakhs, a net profit of INR 2,274.88 lakhs, and an earnings per share of INR 4.32.

Granules India Ltd reported Q2 and H1 FY27 earnings, with revenue growing 20% YoY to INR15,600 million, and EBITDA and PAT increasing 21% and 39% respectively. The company's growth strategy has multiple pillars, including controlled substances, complex generics, geographical expansion, and peptide CDMO.

Granules India Limited has informed the Exchange about the Transcript of the Earnings Conference call for Q2 and the half-year of FY27. The company's revenue grew 20% year-on-year to INR15,600 million, crossing INR15,000 million in quarterly revenue for the first time in its history. EBITDA grew 21%, while PAT increased 39% to INR1,818 million. The company has also uploaded its detailed quarterly presentation and will submit a comprehensive response within 15 business days detailing its corrective and preventive actions following a cGMP inspection by the U.S. FDA.

Blue Jet Healthcare Limited has published unaudited standalone financial results for the quarter and half year ended September 30, 2026, under Regulation 47 of SEBI (LODR) Regulations, 2015.

Signet Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Half yearly/Quarterly Standalone Unaudited Financial Results along with Statement of Assets and Liabilities and Cash Flow Statement for the Half Year/Quarter ended 30th September, 2026.

Symbiotec Pharmalab Limited has signed a 10-year, take-or-pay contract development and manufacturing agreement with a European alternative protein innovator to manufacture fermentation-based alternative protein. The agreement reserves dedicated capacity for the partner at Symbiotec's Ujjain campus for the full term.

Patanjali Foods Limited has submitted a disclosure under regulation 30 of SEBI LODR, announcing its expansion into emerging consumption channels, including e-commerce, and strengthening its institutional business, with a 50% y-o-y growth.

Aravali Securities & Finance Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026, inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2026.

Excel Industries Limited has informed the Exchange about Investor Presentation, enclosing the unaudited Financial Results for the quarter and half year ended September 30, 2026. The Investor Presentation will also be available on the company's website.

KDDL Limited has informed the Exchange about the schedule of its earnings call to discuss operational and financial performance for Q2 & H1FY27.

SIS Limited has made available the audio recording of its earnings call held on November 5, 2026, to discuss the financial results for the quarter ended September 30, 2026.

Suvidhaa Infoserve Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, which were approved by the Board of Directors. The financial results will be made available on the company's website.

Cambridge Technology Enterprises Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 to consider and approve Unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026 along with Limited Review Report.

Minolta Finance Ltd approved unaudited financial results for Q2 FY2026-27, and authorized submission to stock exchanges. The company also approved a proposal to raise funds by issuing secured, non-convertible debentures up to ₹10 Crore. The board meeting was held on November 05, 2026.

Subam Papers Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter/half-year ended 30.09.2026.